Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Including cannabinoids in the treatment of painful schwannomatosis.

Iorno V, Roberto A, Colantonio LB, Landi L, Corli O.

Brain Behav. 2018 May 29:e01011. doi: 10.1002/brb3.1011. [Epub ahead of print] No abstract available.

2.

Tooth Loss and Dental Implant Outcomes-Where is dentistry going? A Survey by SIdP, the Italian Society of Periodontology and Implantology.

Cairo F, Landi L, Gatti C, Rasperini G, Aimetti M; SIdP, the Italian Society of Periodontology and Implantology.

Oral Dis. 2018 May 22. doi: 10.1111/odi.12898. [Epub ahead of print] No abstract available.

PMID:
29787631
3.

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC).

Vecchiarelli S, Passiglia F, D'Incecco A, Gallo M, De Luca A, Rossi E, D'Incà F, Minuti G, Landi L, Bennati C, Spreafico M, D'Arcangelo M, Mazza V, Normanno N, Cappuzzo F.

Oncotarget. 2018 Apr 3;9(25):17554-17563. doi: 10.18632/oncotarget.24785. eCollection 2018 Apr 3.

4.

Combination Therapy of Inhaled Indacaterol/Glycopyrronium for Chronic Obstructive Pulmonary Disease in the Very Elderly: Is It Safe? An Electrocardiographic Evaluation.

Spannella F, Giulietti F, Cesari V, Francioso A, Cocci G, Landi L, Lombardi FE, Borioni E, Bernardi B, Rosettani G, Bordoni V, Iacoacci C, Giordano P, Sarzani R.

Respiration. 2018;95 Suppl 1:22-29. doi: 10.1159/000487182. Epub 2018 Apr 27.

5.

N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly.

Spannella F, Giulietti F, Cocci G, Landi L, Borioni E, Lombardi FE, Rosettani G, Bernardi B, Bordoni V, Giordano P, Bordicchia M, Sarzani R.

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):629-635. doi: 10.1016/j.numecd.2018.02.013. Epub 2018 Feb 27.

PMID:
29650297
6.

Bladder management during pregnancy in women with spinal-cord injury: an observational, multicenter study.

Andretta E, Landi LM, Cianfrocca M, Manassero A, Risi O, Artuso G.

Int Urogynecol J. 2018 Mar 29. doi: 10.1007/s00192-018-3620-8. [Epub ahead of print]

PMID:
29600402
7.

HER2 Deregulation in Lung Cancer: Right Time to Adopt an Orphan?

Cappuzzo F, Landi L.

Clin Cancer Res. 2018 Jun 1;24(11):2470-2472. doi: 10.1158/1078-0432.CCR-18-0198. Epub 2018 Mar 1.

PMID:
29496760
8.

Renin-Angiotensin System Blockers and Statins Are Associated With Lower In-Hospital Mortality in Very Elderly Hypertensives.

Spannella F, Giulietti F, Balietti P, Cocci G, Landi L, Lombardi FE, Borioni E, Bernardi B, Rosettani G, Bordoni V, Sarzani R.

J Am Med Dir Assoc. 2018 Apr;19(4):342-347. doi: 10.1016/j.jamda.2017.09.023. Epub 2017 Nov 8.

PMID:
29128438
9.

A few pills twice a day keep ALK-positive non-small-cell lung cancer at bay.

Landi L, Cappuzzo F.

J Thorac Dis. 2017 Aug;9(8):2311-2314. doi: 10.21037/jtd.2017.07.76. No abstract available.

10.

Ocular perfusion pressure control during pars plana vitrectomy: testing a novel device.

Rossi T, Querzoli G, Gelso A, Angelini G, Rossi A, Corazza P, Landi L, Telani S, Ripandelli G.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2325-2330. doi: 10.1007/s00417-017-3799-2. Epub 2017 Sep 8.

PMID:
28887584
11.

Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.

Spannella F, Giulietti F, Balietti P, Borioni E, Lombardi FE, Ricci M, Cocci G, Landi L, Sarzani R.

J Hypertens. 2017 Nov;35(11):2315-2322. doi: 10.1097/HJH.0000000000001438.

PMID:
28614094
12.

Proximal hypospadias repair with bladder mucosal graft: Our 10 years experience.

Lanciotti M, Betti M, Elia A, Landi L, Taverna M, Cini C, Masieri L.

J Pediatr Urol. 2017 Jun;13(3):294.e1-294.e6. doi: 10.1016/j.jpurol.2017.01.011. Epub 2017 Feb 17.

PMID:
28341425
13.

Global Transcriptome Analysis and Identification of Differentially Expressed Genes in Strawberry after Preharvest Application of Benzothiadiazole and Chitosan.

Landi L, De Miccolis Angelini RM, Pollastro S, Feliziani E, Faretra F, Romanazzi G.

Front Plant Sci. 2017 Feb 24;8:235. doi: 10.3389/fpls.2017.00235. eCollection 2017.

14.

The effectiveness of a nursing discharge programme to improve medication adherence and patient satisfaction in the psychiatric intensive care unit.

Virgolesi M, Pucciarelli G, Colantoni AM, D'Andrea F, Di Donato B, Giorgi F, Landi L, Salustri E, Turci C, Proietti MG.

J Clin Nurs. 2017 Dec;26(23-24):4456-4466. doi: 10.1111/jocn.13776. Epub 2017 May 3.

PMID:
28233457
15.

Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC.

Landi L, Cappuzzo F.

Transl Lung Cancer Res. 2016 Dec;5(6):579-587. doi: 10.21037/tlcr.2016.12.05. Review.

16.

The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.

Gemmill RM, Nasarre P, Nair-Menon J, Cappuzzo F, Landi L, D'Incecco A, Uramoto H, Yoshida T, Haura EB, Armeson K, Drabkin HA.

Sci Signal. 2017 Jan 17;10(462). pii: eaag0528. doi: 10.1126/scisignal.aag0528.

17.

Interarm blood pressure differences predict target organ damage in type 2 diabetes.

Spannella F, Giulietti F, Fedecostante M, Ricci M, Balietti P, Cocci G, Landi L, Bonfigli AR, Boemi M, Espinosa E, Sarzani R.

J Clin Hypertens (Greenwich). 2017 May;19(5):472-478. doi: 10.1111/jch.12963. Epub 2016 Dec 27.

18.

Perioprosthetic and Implant-Supported Rehabilitation of Complex Cases: Clinical Management and Timing Strategy.

Landi L, Piccinelli S, Raia R, Marinotti F, Manicone PF.

Case Rep Dent. 2016;2016:2634093. Epub 2016 Nov 7.

19.

RE: Long-term efficacy of microbiology-driven periodontal laser-assisted therapy, by Martelli et al., Eur J Clin Microbiol Infect Dis 2016, 35(3): 423-431.

Gatti C, Aimetti M, Rasperini G, Landi L, Cairo F; SIdP, Italian Society of Periodontology and Implantology.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):395-397. doi: 10.1007/s10096-016-2785-7. Epub 2016 Oct 13. No abstract available.

20.

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer.

Romanidou O, Landi L, Cappuzzo F, Califano R.

Ther Adv Med Oncol. 2016 May;8(3):176-87. doi: 10.1177/1758834016631531. Epub 2016 Feb 16. Review.

21.

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

Califano R, Romanidou O, Mountzios G, Landi L, Cappuzzo F, Blackhall F.

Drugs. 2016 May;76(8):831-40. doi: 10.1007/s40265-016-0578-z. Review.

PMID:
27129321
22.

Assessing the toxicity of sediments using the medaka embryo-larval assay and 2 other bioassays.

Barhoumi B, Clérandeau C, Landi L, Pichon A, Le Bihanic F, Poirier D, Anschutz P, Budzinski H, Driss MR, Cachot J.

Environ Toxicol Chem. 2016 Sep;35(9):2270-80. doi: 10.1002/etc.3388. Epub 2016 Jun 15.

PMID:
26823140
23.

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.

Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Fassan M, Cappuzzo F, Croce CM.

Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14924-9. doi: 10.1073/pnas.1520329112. Epub 2015 Nov 16.

24.

Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer.

Landi L, Cappuzzo F.

Expert Rev Clin Pharmacol. 2016;9(2):203-14. doi: 10.1586/17512433.2016.1122518. Epub 2015 Dec 16. Review.

PMID:
26582431
25.

Genetic Variability of Stolbur Phytoplasma in Hyalesthes obsoletus (Hemiptera: Cixiidae) and its Main Host Plants in Vineyard Agroecosystems.

Landi L, Riolo P, Murolo S, Romanazzi G, Nardi S, Isidoro N.

J Econ Entomol. 2015 Aug;108(4):1506-15. doi: 10.1093/jee/tov103. Epub 2015 May 7.

PMID:
26470289
26.

MET deregulation in breast cancer.

Minuti G, Landi L.

Ann Transl Med. 2015 Aug;3(13):181. doi: 10.3978/j.issn.2305-5839.2015.06.22. Review.

27.

Preharvest treatments with chitosan and other alternatives to conventional fungicides to control postharvest decay of strawberry.

Feliziani E, Landi L, Romanazzi G.

Carbohydr Polym. 2015 Nov 5;132:111-7. doi: 10.1016/j.carbpol.2015.05.078. Epub 2015 Jun 8.

PMID:
26256331
28.

Experience with erlotinib in the treatment of non-small cell lung cancer.

Landi L, Cappuzzo F.

Ther Adv Respir Dis. 2015 Aug;9(4):146-63. doi: 10.1177/1753465815588053. Epub 2015 Jun 10. Review.

PMID:
26063687
29.

Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.

D'Arcangelo M, Todaro M, Salvini J, Benfante A, Colorito ML, D'Incecco A, Landi L, Apuzzo T, Rossi E, Sani S, Stassi G, Cappuzzo F.

PLoS One. 2015 May 8;10(5):e0125037. doi: 10.1371/journal.pone.0125037. eCollection 2015.

30.

Recommendations on complementary feeding for healthy, full-term infants.

Alvisi P, Brusa S, Alboresi S, Amarri S, Bottau P, Cavagni G, Corradini B, Landi L, Loroni L, Marani M, Osti IM, Povesi-Dascola C, Caffarelli C, Valeriani L, Agostoni C.

Ital J Pediatr. 2015 Apr 28;41:36. doi: 10.1186/s13052-015-0143-5. Review.

31.

Platform switching vs standard implants in partially edentulous patients using the Dental Tech Implant System: clinical and radiological results from a prospective multicenter study.

Del Fabbro M, Bianchessi C, Del Lupo R, Landi L, Taschieri S, Corbella S.

Clin Oral Investig. 2015 Dec;19(9):2233-44. doi: 10.1007/s00784-015-1462-z. Epub 2015 Mar 31.

PMID:
25820990
32.

Writing in PROSE proteomic-based selection for second line treatment in non-small-cell lung cancer.

Landi L, Cappuzzo F.

Ann Transl Med. 2015 Mar;3(3):32. doi: 10.3978/j.issn.2305-5839.2015.02.12. No abstract available.

33.

Targeting MET in NSCLC: looking for a needle in a haystack.

Landi L, Cappuzzo F.

Transl Lung Cancer Res. 2014 Dec;3(6):389-91. doi: 10.3978/j.issn.2218-6751.2014.11.05. No abstract available.

34.

Prolapsed vaginal ureterocele as a cause of urinary incontinence in a child.

Landi L, Elia A, Adorisio O.

Urol J. 2015 Feb 22;12(1):1999-2000. No abstract available.

35.

Nit-picking around second line in EGFRwt NSCLC: just an academic effort.

Landi L, Cappuzzo F.

Ann Oncol. 2015 Mar;26(3):448-50. doi: 10.1093/annonc/mdu575. Epub 2014 Dec 19. No abstract available.

PMID:
25527415
36.

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients.

D'Incecco A, Andreozzi M, Ludovini V, Rossi E, Capodanno A, Landi L, Tibaldi C, Minuti G, Salvini J, Coppi E, Chella A, Fontanini G, Filice ME, Tornillo L, Incensati RM, Sani S, Crinò L, Terracciano L, Cappuzzo F.

Br J Cancer. 2015 Jan 6;112(1):95-102. doi: 10.1038/bjc.2014.555. Epub 2014 Oct 28.

37.

Management of NSCLC: focus on crizotinib.

Landi L, Cappuzzo F.

Expert Opin Pharmacother. 2014 Dec;15(17):2587-97. doi: 10.1517/14656566.2014.970174. Epub 2014 Oct 10. Review.

PMID:
25301075
38.

Activity of the EGFR-HER2 dual inhibitor afatinib in EGFR-mutant lung cancer patients with acquired resistance to reversible EGFR tyrosine kinase inhibitors.

Landi L, Tiseo M, Chiari R, Ricciardi S, Rossi E, Galetta D, Novello S, Milella M, D'Incecco A, Minuti G, Tibaldi C, Salvini J, Facchinetti F, Haspinger ER, Cortinovis D, Santo A, Banna G, Catino A, GiajLevra M, Crinò L, de Marinis F, Cappuzzo F.

Clin Lung Cancer. 2014 Nov;15(6):411-417.e4. doi: 10.1016/j.cllc.2014.07.002. Epub 2014 Aug 16.

39.

Pharmacotherapy targeting the EGFR oncogene in NSCLC.

Landi L, Cappuzzo F.

Expert Opin Pharmacother. 2014 Nov;15(16):2293-305. doi: 10.1517/14656566.2014.957179. Epub 2014 Sep 13. Review.

PMID:
25219817
40.

Ceritinib for the treatment of non-small cell lung cancer.

Landi L, Cappuzzo F.

Drugs Today (Barc). 2014 Jul;50(7):465-73. doi: 10.1358/dot.2014.50.7.2133568. Review.

PMID:
25101329
41.

Chronic dietary exposure of zebrafish to PAH mixtures results in carcinogenic but not genotoxic effects.

Larcher T, Perrichon P, Vignet C, Ledevin M, Le Menach K, Lyphout L, Landi L, Clerandeau C, Lebihanic F, Ménard D, Burgeot T, Budzinski H, Akcha F, Cachot J, Cousin X.

Environ Sci Pollut Res Int. 2014 Dec;21(24):13833-49. doi: 10.1007/s11356-014-2923-7. Epub 2014 Apr 30.

PMID:
24777325
42.

Transcriptional responses and embryotoxic effects induced by pyrene and methylpyrene in Japanese medaka (Oryzias latipes) early life stages exposed to spiked sediments.

Barjhoux I, Cachot J, Gonzalez P, Budzinski H, Le Menach K, Landi L, Morin B, Baudrimont M.

Environ Sci Pollut Res Int. 2014 Dec;21(24):13850-66. doi: 10.1007/s11356-014-2895-7. Epub 2014 Apr 23.

PMID:
24756688
43.

Protein kinase inhibitors to treat non-small-cell lung cancer.

Minuti G, D'Incecco A, Landi L, Cappuzzo F.

Expert Opin Pharmacother. 2014 Jun;15(9):1203-13. doi: 10.1517/14656566.2014.909412. Epub 2014 Apr 19. Review.

PMID:
24745764
44.

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.

Bajetta E, Floriani I, Di Bartolomeo M, Labianca R, Falcone A, Di Costanzo F, Comella G, Amadori D, Pinto C, Carlomagno C, Nitti D, Daniele B, Mini E, Poli D, Santoro A, Mosconi S, Casaretti R, Boni C, Pinotti G, Bidoli P, Landi L, Rosati G, Ravaioli A, Cantore M, Di Fabio F, Aitini E, Marchet A; ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group.

Ann Oncol. 2014 Jul;25(7):1373-8. doi: 10.1093/annonc/mdu146. Epub 2014 Apr 12.

PMID:
24728035
45.

Expression of Defense Genes in Strawberry Fruits Treated with Different Resistance Inducers.

Landi L, Feliziani E, Romanazzi G.

J Agric Food Chem. 2014 Apr 9;62(14):3047-3056. doi: 10.1021/jf404423x. Epub 2014 Mar 26.

PMID:
24627944
46.

Development of a reference artificial sediment for chemical testing adapted to the MELA sediment contact assay.

Le Bihanic F, Perrichon P, Landi L, Clérandeau C, Le Menach K, Budzinski H, Cousin X, Cachot J.

Environ Sci Pollut Res Int. 2014 Dec;21(24):13689-702. doi: 10.1007/s11356-014-2607-3. Epub 2014 Feb 15.

PMID:
24526399
47.

MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies.

Cappuzzo F, Sacconi A, Landi L, Ludovini V, Biagioni F, D'Incecco A, Capodanno A, Salvini J, Corgna E, Cupini S, Barbara C, Fontanini G, Crinò L, Blandino G.

Clin Colorectal Cancer. 2014 Mar;13(1):37-45.e4. doi: 10.1016/j.clcc.2013.11.006. Epub 2013 Nov 14.

PMID:
24503111
48.

Specific aquaporins facilitate Nox-produced hydrogen peroxide transport through plasma membrane in leukaemia cells.

Vieceli Dalla Sega F, Zambonin L, Fiorentini D, Rizzo B, Caliceti C, Landi L, Hrelia S, Prata C.

Biochim Biophys Acta. 2014 Apr;1843(4):806-14. doi: 10.1016/j.bbamcr.2014.01.011. Epub 2014 Jan 16.

49.

HER2 and lung cancer.

Landi L, Cappuzzo F.

Expert Rev Anticancer Ther. 2013 Oct;13(10):1219-28. doi: 10.1586/14737140.2013.846830. Review.

PMID:
24134423
50.

Surgical treatment options for grafting areas of gingival recession association with cervical lesions: a review.

Bignozzi I, Littarru C, Crea A, Vittorini Orgeas G, Landi L.

J Esthet Restor Dent. 2013 Dec;25(6):371-82. doi: 10.1111/jerd.12058. Epub 2013 Sep 17. Review.

PMID:
24103046

Supplemental Content

Support Center